How should high cholesterol, mutation negative children, identified through the child-parent screening project be managed?

• L. Priestley-Barnham,
• A. Morris,
• P. Dale,
• S.E. Humphries,
• U. Ramaswami

Affiliations

L. Priestley-Barnham

Royal Brompton & Harefield NHS Foundation Trust, Harefield Hospital, London

A. Morris

Willink Metabolic Unit, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

P. Dale

Department of Paediatrics, Royal Gwent Hospital, Newport, Wales

S.E. Humphries

Centre for Cardiovascular Genetics, University College London, London

U. Ramaswami

Lysosomal Disorders Unit, Royal Free Hospital, London